Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1987 1
1990 3
1991 1
1992 1
1996 1
2000 2
2003 1
2012 1
2013 1
2014 1
2015 1
2017 1
2018 3
2019 3
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Estradiol-containing birth control pill"
Page 1
Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk.
Morimont L, Haguet H, Dogné JM, Gaspard U, Douxfils J. Morimont L, et al. Front Endocrinol (Lausanne). 2021 Dec 9;12:769187. doi: 10.3389/fendo.2021.769187. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34956081 Free PMC article. Review.
In this review, we discuss the numerous strategies that have been implemented to reduce the thrombotic risk associated with combined oral contraceptives (COCs) from their arrival on the market until today. ...In 2009, estradiol-containing COCs were mar …
In this review, we discuss the numerous strategies that have been implemented to reduce the thrombotic risk associated with combined oral …
Systemic hormonal contraception and risk of venous thromboembolism.
Heikinheimo O, Toffol E, Partonen T, But A, Latvala A, Haukka J. Heikinheimo O, et al. Acta Obstet Gynecol Scand. 2022 Aug;101(8):846-855. doi: 10.1111/aogs.14384. Epub 2022 May 27. Acta Obstet Gynecol Scand. 2022. PMID: 35633036 Free PMC article.
Current use of estradiol-containing preparations was not associated with venous thromboembolism risk after exclusion of cyproterone-acetate and estrogen/ethinylestradiol (aOR 1.05; 95% CI 0.66-1.66). CONCLUSIONS: An increased risk of venous thromboembolism is associ …
Current use of estradiol-containing preparations was not associated with venous thromboembolism risk after exclusion of cyprot …
Zoely: a new combined oral contraceptive.
[No authors listed] [No authors listed] Drug Ther Bull. 2014 Aug;52(8):90-3. doi: 10.1136/dtb.2014.8.0270. Epub 2014 Aug 7. Drug Ther Bull. 2014. PMID: 25104773 Review.
Zoely is the second estradiol-containing oral contraceptive formulated as an 'extended regimen' (pill-free interval <7 days) to be licensed in the UK. However, unlike the quadraphasic estradiol-containing contraceptive Qlaira, it is a …
Zoely is the second estradiol-containing oral contraceptive formulated as an 'extended regimen' (pill-free inter …
The current status of hormonal therapies for heavy menstrual bleeding.
Heikinheimo O, Fraser I. Heikinheimo O, et al. Best Pract Res Clin Obstet Gynaecol. 2017 Apr;40:111-120. doi: 10.1016/j.bpobgyn.2017.01.001. Epub 2017 Jan 21. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 28238590 Review.
In the present article, we review the efficacy of the commonly used and widely available hormonal treatments of AUB-O, AUB-E and AUB-C. The therapies include combined hormonal contraceptives, progestin-only preparations, and intrauterine release of levonorgestrel through t …
In the present article, we review the efficacy of the commonly used and widely available hormonal treatments of AUB-O, AUB-E and AUB-C. The …
Oral contraceptives, lipoproteins, and atherosclerosis.
Adams MR, Clarkson TB, Shively CA, Parks JS, Kaplan JR. Adams MR, et al. Am J Obstet Gynecol. 1990 Oct;163(4 Pt 2):1388-93. doi: 10.1016/0002-9378(90)91353-e. Am J Obstet Gynecol. 1990. PMID: 2220963
However, contrary to what might be expected, use of the ethinyl estradiol-containing oral contraceptives did not lead to an increase in the prevalence or extent of atherosclerosis. We concluded that ethinyl estradiol neutralized the atherogenic influen …
However, contrary to what might be expected, use of the ethinyl estradiol-containing oral contraceptives did not …
Norgestimate: a clinical overview of a new progestin.
Bringer J. Bringer J. Am J Obstet Gynecol. 1992 Jun;166(6 Pt 2):1969-77. doi: 10.1016/0002-9378(92)91397-s. Am J Obstet Gynecol. 1992. PMID: 1605287 Review.
The efficacy and safety of a new monophasic oral contraceptive, norgestimate/ethinyl estradiol, containing the third-generation progestin, norgestimate (250 micrograms), and ethinyl estradiol (35 micrograms), are reviewed. ...Researchers have found that or …
The efficacy and safety of a new monophasic oral contraceptive, norgestimate/ethinyl estradiol, containing the third-ge …
A randomized trial comparing the 52-mg levonorgestrel system with combination oral contraceptives for treatment of heavy menstrual bleeding.
Matteson KA, Valcin J, Raker CA, Clark MA. Matteson KA, et al. Am J Obstet Gynecol. 2023 Nov;229(5):532.e1-532.e13. doi: 10.1016/j.ajog.2023.07.049. Epub 2023 Aug 1. Am J Obstet Gynecol. 2023. PMID: 37536486 Clinical Trial.
BACKGROUND: The levonorgestrel intrauterine system and combined oral contraceptives are the 2 most commonly used nonsurgical treatments for heavy menstrual bleeding in the United States. ...Patients should be counseled that the levonorgestrel intrauterine system and …
BACKGROUND: The levonorgestrel intrauterine system and combined oral contraceptives are the 2 most commonly used nonsurgical t …
Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium.
Nilsson O, Englund D, Weiner E, Victor A. Nilsson O, et al. Contraception. 1980 Jul;22(1):71-83. doi: 10.1016/0010-7824(80)90119-5. Contraception. 1980. PMID: 6774851
Ciliated cells were seldon encountered, and the non-ciliated cells possessed mostly only few short microvilli. When menopausal women had been wearing estradiol-containing intravaginal rings for three weeks, the uterine surface had developed many ciliated cells, and …
Ciliated cells were seldon encountered, and the non-ciliated cells possessed mostly only few short microvilli. When menopausal women had bee …
Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
Poindexter AN, Burkman R, Fisher AC, LaGuardia KD. Poindexter AN, et al. Int J Fertil Womens Med. 2003 Jul-Aug;48(4):163-72. Int J Fertil Womens Med. 2003. PMID: 13677549 Clinical Trial.
OBJECTIVE: To determine cycle control, tolerability, and satisfaction among women (aged 18-45) switching from oral contraceptives (OCs) containing 30-35 microg ethinyl estradiol (EE) to Ortho Tri-Cyclen LO (norgestimate 180/215/250 microg/EE 25 microg) and Lo …
OBJECTIVE: To determine cycle control, tolerability, and satisfaction among women (aged 18-45) switching from oral contrace …
Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: a randomised clinical trial.
Ackerman KE, Singhal V, Baskaran C, Slattery M, Campoverde Reyes KJ, Toth A, Eddy KT, Bouxsein ML, Lee H, Klibanski A, Misra M. Ackerman KE, et al. Br J Sports Med. 2019 Feb;53(4):229-236. doi: 10.1136/bjsports-2018-099723. Epub 2018 Oct 9. Br J Sports Med. 2019. PMID: 30301734 Free PMC article. Clinical Trial.
METHODS: 121 patients with OAA aged 14-25 years were randomised to receive: (1) a 17beta-estradiol transdermal patch continuously with cyclic oral micronised progesterone (PATCH), (2) a combined ethinyl estradiol and desogestrel pill (PILL) or (3) no oestroge …
METHODS: 121 patients with OAA aged 14-25 years were randomised to receive: (1) a 17beta-estradiol transdermal patch continuously with cycli …
23 results